Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease. (July 2017)

• Record Type: Journal Article
• Authors: Michaud, Tzeyu L.; High, Robin; Charlton, Mary E.; Murman, Daniel L.
• Is Part Of: Alzheimer disease and associated disorders. Volume 31:Number 3(2017)
• Publication Date: 2017-07
• Subjects: Alzheimer disease -- dependence scale -- costs of care -- quality of life -- pharmacoeconomic evaluation -- disease stage; Alzheimer's disease -- Periodicals; Dementia -- Periodicals; 616.8305
• DOI: 10.1097/WAD.0000000000000198
• Languages: English
• ISSNs: 0893-0341

Abstract

Abstract : The level of assistance patients with Alzheimer disease (AD) require in their care may be an important predictor of resource use, costs of care, and quality of life. The Dependence Scale (DS), a measure of care-assistance required, was used to estimate costs of care and quality of life of patients with AD categorized into 6 dependence stages based upon the summated item scores of the DS. Data were derived from a 3-year, noninterventional study of 132 patients with probable AD (ages, 50 to 85 y) and caregiver dyads. We investigated the association between DS scores and health care costs, health-related quality of life (HRQoL), caregiver burden and estimated annual costs and HRQoL for 6 dependence stages in adjusted models. DS scores were significant predictors of health care costs, HRQoL, and caregiver burden. The estimated annual health care costs and a measure of HRQoL (EuroQoL-5D) ranged from $11, 418 and 1.00 for those at very mild dependence stage to $101, 715 and 0.26 for those at very severe dependence stage. DS scores classified into 6 dependence stages provides a useful method to estimate unique levels of care-associated costs and health utilities for pharmacoeconomic evaluations of new treatments for AD. Abstract : Supplemental Digital Content is available in the text.